Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Alzheimer's Disease

  Free Subscription

Articles published in Exp Gerontol

Retrieve available abstracts of 45 articles:
HTML format

Single Articles

    April 2020
  1. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    PubMed     Abstract available

  2. MUNDO IG, Vielma NMP, Lopez MG, Fleury A, et al
    DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease.
    Exp Gerontol. 2020 Apr 16:110951. doi: 10.1016/j.exger.2020.110951.
    PubMed     Abstract available

  3. SCARABINO D, Peconi M, Broggio E, Gambina G, et al
    Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
    Exp Gerontol. 2020;136:110945.
    PubMed     Abstract available

  4. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Corrigendum to "Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study" [Exp. Gerontol. 131 (2020) 110816].
    Exp Gerontol. 2020 Apr 8:110943. doi: 10.1016/j.exger.2020.110943.

    March 2020
  5. MOREL E, Armand S, Assal F, Allali G, et al
    Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Exp Gerontol. 2020 Mar 2:110905. doi: 10.1016/j.exger.2020.110905.
    PubMed     Abstract available

    February 2020
  6. SINGULANI MP, Pereira CPM, Ferreira AFF, Garcia PC, et al
    Impairment of PGC-1alpha-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease.
    Exp Gerontol. 2020 Feb 18:110882. doi: 10.1016/j.exger.2020.110882.
    PubMed     Abstract available

    December 2019
  7. ZHAO J, Liu P, Hua L, Yang X, et al
    Haplotype analysis on association between variants of interleukin 6 (IL-6) and late-onset Alzheimer's disease in a Chinese Han population.
    Exp Gerontol. 2019 Dec 21:110813. doi: 10.1016/j.exger.2019.110813.
    PubMed     Abstract available

  8. DE OLIVEIRA SILVA F, Ferreira JV, Placido J, Chagas D, et al
    Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: A cross-sectional study.
    Exp Gerontol. 2019 Dec 17:110816. doi: 10.1016/j.exger.2019.110816.
    PubMed     Abstract available

  9. CAO F, Liu Z, Sun G
    Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-beta induced neurotoxicity by targeting PTEN.
    Exp Gerontol. 2019;130:110814.
    PubMed     Abstract available

    October 2019
  10. ARIANNA V, Sonila A, Sofia P, Alessia G, et al
    Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2019 Oct 21:110754. doi: 10.1016/j.exger.2019.110754.
    PubMed     Abstract available

    August 2019
  11. ALTINOZ MA, Guloksuz S, Schmidt-Kastner R, Kenis G, et al
    Involvement of hemoglobins in the pathophysiology of Alzheimer's disease.
    Exp Gerontol. 2019 Aug 2:110680. doi: 10.1016/j.exger.2019.110680.
    PubMed     Abstract available

    June 2019
  12. ISIK AT, Kocyigit SE, Smith L, Aydin AE, et al
    A comparison of the prevalence of orthostatic hypotension between older patients with Alzheimer's Disease, Lewy body dementia, and without dementia.
    Exp Gerontol. 2019 Jun 4. pii: S0531-5565(19)30202.
    PubMed     Abstract available

    May 2019
  13. PENA-BAUTISTA C, Baquero M, Ferrer I, Hervas D, et al
    Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients.
    Exp Gerontol. 2019 May 19. pii: S0531-5565(19)30198.
    PubMed     Abstract available

    April 2019
  14. JENSEN CS, Bahl JM, Ostergaard LB, Hogh P, et al
    Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
    Exp Gerontol. 2019 Apr 10. pii: S0531-5565(18)30714.
    PubMed     Abstract available

    February 2019
  15. HAYASHI K, Hasegawa Y, Takemoto Y, Cao C, et al
    Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.
    Exp Gerontol. 2019 Feb 17. pii: S0531-5565(18)30570.
    PubMed     Abstract available

    January 2019
  16. ZENG Q, Siu W, Li L, Jin Y, et al
    Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine.
    Exp Gerontol. 2019 Jan 30. pii: S0531-5565(18)30772.
    PubMed     Abstract available

  17. MURALEVA NA, Stefanova NA, Kolosova NG
    p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2019 Jan 18. pii: S0531-5565(18)30613.
    PubMed     Abstract available

    December 2018
  18. ABRAHAM D, Feher J, Scuderi GL, Szabo D, et al
    Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome.
    Exp Gerontol. 2018 Dec 6. pii: S0531-5565(18)30638.
    PubMed     Abstract available

    November 2018
  19. BEAUCHET O, Launay CP, Sekhon H, Montembeault M, et al
    Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study.
    Exp Gerontol. 2018 Nov 14. pii: S0531-5565(18)30586.
    PubMed     Abstract available

  20. RUDNITSKAYA EA, Kozlova TA, Burnyasheva AO, Kolosova NG, et al
    Alterations of hippocampal neurogenesis during development of Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2018 Nov 8. pii: S0531-5565(18)30409.
    PubMed     Abstract available

    September 2018
  21. DRYGALSKI K, Fereniec E, Korycinski K, Chomentowski A, et al
    Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
    Exp Gerontol. 2018;113:36-47.

    August 2018
  22. HUTTER-SCHMID B, Humpel C
    Primary mouse brain pericytes isolated from transgenic Alzheimer mice spontaneously differentiate into a CD11b(+) microglial-like cell type in vitro.
    Exp Gerontol. 2018 Aug 9. pii: S0531-5565(18)30435.
    PubMed     Abstract available

    July 2018
  23. TOROSYAN N, Sethanandha C, Grill JD, Dilley ML, et al
    Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Exp Gerontol. 2018;111:118-121.
    PubMed     Abstract available

    June 2018
  24. SHEKHAR S, Yadav Y, Singh AP, Pradhan R, et al
    Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.
    Exp Gerontol. 2018 Jun 27. pii: S0531-5565(18)30302.
    PubMed     Abstract available

  25. BUFFA R, Mereu E, Putzu P, Mereu RM, et al
    Corrigendum to "Lower lean mass and higher percent fat mass in patients with Alzheimer's disease" [Exp. Gerontol. 58 (2014) 30-33].
    Exp Gerontol. 2018 Jun 2. pii: S0531-5565(18)30330.

    April 2018
  26. KUGA GK, Munoz VR, Gaspar RC, Nakandakari SCBR, et al
    Impaired insulin signaling and spatial learning in middle-aged rats: The role of PTP1B.
    Exp Gerontol. 2018;104:66-71.
    PubMed     Abstract available

    March 2018
  27. KUNUTSOR SK, Laukkanen JA, Burgess S
    Genetically elevated gamma-glutamyltransferase and Alzheimer's disease.
    Exp Gerontol. 2018 Mar 2. pii: S0531-5565(18)30042.
    PubMed     Abstract available

    January 2018
  28. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Abstract available

    December 2017
  29. LE PAGE A, Dupuis G, Frost EH, Larbi A, et al
    Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Exp Gerontol. 2017 Dec 21. pii: S0531-5565(17)30541.
    PubMed     Abstract available

    November 2017
  30. MEREU E, Succa V, Buffa R, Sanna C, et al
    Total body and arm bioimpedance in patients with Alzheimer's disease.
    Exp Gerontol. 2017 Nov 21. pii: S0531-5565(17)30668.
    PubMed     Abstract available

    October 2017
  31. YASHIN AI, Fang F, Kovtun M, Wu D, et al
    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
    Exp Gerontol. 2017 Oct 26. pii: S0531-5565(17)30424.
    PubMed     Abstract available

  32. MATHYS J, Gholamrezaee M, Henry H, von Gunten A, et al
    Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Exp Gerontol. 2017 Oct 17. pii: S0531-5565(17)30465.
    PubMed     Abstract available

  33. FARINA N, Jerneren F, Turner C, Hart K, et al
    Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Exp Gerontol. 2017 Oct 9. pii: S0531-5565(17)30374.
    PubMed     Abstract available

    August 2017
  34. SCARABINO D, Broggio E, Gambina G, Corbo RM, et al
    Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2017 Aug 18. pii: S0531-5565(17)30445.
    PubMed     Abstract available

    July 2017
  35. CROTEAU E, Castellano CA, Fortier M, Bocti C, et al
    A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Exp Gerontol. 2017 Jul 11. pii: S0531-5565(17)30228.
    PubMed     Abstract available

    May 2017
  36. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Abstract available

    March 2017
  37. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Abstract available

    February 2017
  38. HUANG M, Jiang X, Liang Y, Liu Q, et al
    Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Exp Gerontol. 2017;91:25-33.
    PubMed     Abstract available

  39. MACKLIN L, Griffith CM, Cai Y, Rose GM, et al
    Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Exp Gerontol. 2017;88:9-18.
    PubMed     Abstract available

    January 2017
  40. GARD PR, Fidalgo S, Lotter I, Richardson C, et al
    Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Exp Gerontol. 2017 Jan 6. pii: S0531-5565(17)30006.
    PubMed     Abstract available

    December 2016
  41. SCARABINO D, Broggio E, Gambina G, Pelliccia F, et al
    Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimer's disease.
    Exp Gerontol. 2016 Dec 27. pii: S0531-5565(16)30423.
    PubMed     Abstract available

  42. BARRON M, Gartlon J, Dawson LA, Atkinson PJ, et al
    A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.
    Exp Gerontol. 2016 Dec 12. pii: S0531-5565(16)30580.
    PubMed     Abstract available

  43. NAKAGAWA T, Hasegawa Y, Uekawa K, Kim-Mitsuyama S, et al
    Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Exp Gerontol. 2016 Dec 1. pii: S0531-5565(16)30318.
    PubMed     Abstract available

    November 2016
  44. TARANTINI S, Tran CH, Gordon GR, Ungvari Z, et al
    Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
    Exp Gerontol. 2016 Nov 11. pii: S0531-5565(16)30399.
    PubMed     Abstract available

    September 2016
  45. ZHANG ZX, Zhao RP, Wang DS, Wang AN, et al
    Fuzhisan ameliorates Abeta production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Exp Gerontol. 2016;84:88-95.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.